Check out our most popular compounded medications! Get Started
Bayview Pharmacy offers Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules, a compounded formulation designed to treat conditions such as menopause, osteoporosis, uterine fibroids, endometriosis, and vulvovaginal atrophy. The capsules utilize a controlled-release polymer, Methocel E4M, to gradually release the encapsulated medication over an extended period. This ensures sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules is a specially compounded medication designed to treat a range of health conditions. This formulation combines estriol and estradiol, two hormones naturally produced by the body, in an 80%-20% ratio. The dosage range for this medication is 0.5 - 1.25 mg, and it is available in both troche and slow release capsule forms.
The slow release capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This sustained release offers prolonged therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and extended release profile.
Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules can be used to treat a variety of conditions. These include menopausal symptoms, endometriosis, and uterine fibroids. It can also be used to manage osteoporosis, reduce the risk of cardiovascular disease and stroke, alleviate symptoms of premenstrual syndrome (PMS), and decrease the risk of breast cancer.
However, it is crucial to note that this medication should only be used under the supervision of a healthcare provider due to potential side effects such as nausea, headaches, and breast tenderness.
If you have any questions about Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules, please do not hesitate to reach out. We are a team of compounding pharmacists dedicated to providing comprehensive information and support.
This compounded formulation of Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules is designed to provide a balanced approach to hormone replacement therapy. It combines two naturally occurring forms of estrogen, estriol and estradiol. Estriol is a weaker form of estrogen, while estradiol is a stronger form. This combination is used to treat a variety of conditions, including menopausal symptoms, postmenopausal osteoporosis, and as part of hormone replacement therapy.
When used to manage menopausal symptoms, this formulation can help alleviate hot flashes, night sweats, and vaginal dryness. It also plays a crucial role in reducing the risk of osteoporosis in postmenopausal women. Furthermore, this formulation can be used in hormone replacement therapy, which may help lower the risk of certain types of cancer, such as breast and ovarian cancer.
It's important to be aware that this formulation of Estriol/Estradiol may interact with certain medications, including anticoagulants, anticonvulsants, and certain antibiotics. Additionally, it may increase the risk of certain side effects, such as nausea, vomiting, and headaches. Therefore, it is crucial to discuss any potential interactions or side effects with your healthcare provider before starting this medication.
Formulated with Methocel E4M, a type of controlled-release polymer, these capsules are designed to release the encapsulated medication gradually over an extended period. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
If you have any questions about this formulation of Estriol/Estradiol, please do not hesitate to reach out. We are here to provide the necessary information and support.
This formulation combines estriol and estradiol in an 80%-20% ratio, encapsulated in 0.5 - 1.25 mg troche/slow release capsules. These hormones, naturally produced by the body, are supplemented by this formulation to manage various health conditions such as menopausal symptoms, osteoporosis, and vaginal atrophy.
The medication works by supplying the body with the necessary hormones to alleviate symptoms associated with these conditions. Estriol and estradiol synergistically work to mitigate menopausal symptoms like hot flashes and night sweats. They also contribute to the reduction of bone loss and enhancement of bone density, thereby helping to prevent or lower the risk of osteoporosis. Furthermore, estriol and estradiol can alleviate vaginal dryness and promote vaginal health.
This formulation is administered orally, typically once or twice daily. It is crucial to adhere to the prescribed dosage by your healthcare provider and avoid taking more or less than recommended. It's worth noting that the medication may take several weeks to start showing effects and several months to reach its full potential.
If you have any queries about this formulation or its mechanism in treating these health conditions, please feel free to contact us. We are here to assist you in understanding how this formulation works and how it can benefit you.
This compounded formulation of Estriol/Estradiol [80%-20%] 0.5 - 1.25 mg Troche/Slow Release Capsules is designed to provide a controlled and prolonged release of the active ingredients. The formulation is encapsulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the medication over an extended period. This feature offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.
The formulation is versatile and can be used to treat a variety of conditions. It is commonly used in hormone replacement therapy for transgender individuals, post-menopausal women, and pre-menopausal women.
Furthermore, this formulation can be used to alleviate symptoms of adrenal insufficiency, including fatigue, low blood pressure, and low blood sugar. It is also beneficial in treating symptoms of hypogonadism, such as decreased libido, erectile dysfunction, and infertility. If you have any questions about how this formulation can be used to treat any of these conditions, please reach out for more information.
This is a compounded formulation of Estriol and Estradiol, two forms of estrogen, in a ratio of 80% to 20%. The medication is encapsulated in a controlled-release polymer, Methocel E4M, which allows for a gradual release of the active ingredients over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosage of this formulation ranges from 0.5 to 1.25 mg. The exact dosage will depend on the specific needs and response of the individual patient.
Due to the slow-release nature of this formulation, the frequency of dosing is typically reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and response to the medication.
As with any medication, potential side effects can occur. These may include symptoms such as nausea, bloating, breast tenderness, and headache. If you experience any unusual or severe side effects, you should contact your healthcare provider immediately.
Estrogens should not be used during pregnancy or breastfeeding unless specifically directed by your healthcare provider. If you are pregnant, planning to become pregnant, or breastfeeding, you should discuss this with your healthcare provider before starting this medication.
Before starting any new medication, you should always inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, vitamins, and herbal supplements. Some medications may interact with estrogens, affecting their effectiveness or increasing the risk of side effects.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
This medication should be stored at room temperature, away from light and moisture. Keep it out of reach of children and pets. Do not store in the bathroom. Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
